Market Overview:
The global rhinosinusitis drug market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of sinusitis, rising awareness about rhinosinusitis and its treatment options, and technological advancements in the field of sinus surgery. The antibiotics segment is expected to dominate the global rhinosinusitis drug market during the forecast period owing to their high efficacy in treating various types of sinus infections. The corticosteroids segment is projected to grow at a higher CAGR than other segments during the forecast period due to their ability to provide relief from inflammation and other symptoms associated with sinusitis.
Product Definition:
Rhinosinusitis is a condition that affects the sinuses, which are small, air-filled cavities in the skull behind the nose. Rhinosinusitis can cause pain and swelling in these areas and may lead to problems with breathing.
Antibiotics:
Antibiotics are drugs used to treat bacterial infections. Bacterial infection includes ear, urinary tract, pneumonia, and skin infections. Antibiotics can be administered in two ways: by mouth (oral or parenteral) or directly into the blood stream (intravenous). The most commonly prescribed antibiotics are penicillin based antibiotics such as amoxicillin and benzylpenicillin.
Corticosteroids:
Corticosteroids are naturally occurring hormones that are found in the adrenal glands. Corticosteroid drugs include prednisolone, betamethasone, dexamethasone sodium phosphate, fluorometholone, loteprednol, rimexolone and others. Prednisolone is a type of corticosteroid used to treat inflammation and pain caused by asthma or allergies.
Application Insights:
The acute sinusitis segment dominated the global rhinosinusitis drug market in 2017. The segment is expected to witness a CAGR of XX% over the forecast period owing to an increase in number of patients with acute sinusitis and growing awareness about early diagnosis and treatment options for this condition.
Acute rhinosinusitis is usually diagnosed based on history, physical examination, nasal endoscopy and medical imaging studies such as CT or MRI scan. Patients suffering from severe pain in the face along with a high fever are recommended to seek medical attention as soon as possible because it may indicate that there is an infection present inside the skull base region which needs immediate treatment with antibiotics or surgery may be required to remove blockage caused due to swelling inside nose ¢â‚¬Ëœrhinorrhea¢â‚¬â„¢s tip (nasal polyps).
Regional Analysis:
North America dominated the global rhinosinusitis drug market in 2017. The presence of a large number of key players, favorable reimbursement scenario, and high healthcare expenditure are some factors responsible for its dominance. In addition, increasing prevalence of sinusitis is also expected to drive growth during the forecast period. According to data published by CDC in 2018, more than 20 million adults were diagnosed with sinusitis annually between 2010 and 2014.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising healthcare spending by governments along with an increase in awareness regarding chronic diseases such as rhinosinusitis among patients & general public as well as physicians’ consultation rates for treatment purposes have increased significantly over past few years which has boosted demand for drugs used for treating this condition thus driving overall market growth during the estimated time frame 8th edition/revised edition 2016; 9th edition 2017).
Growth Factors:
- Increasing incidence of rhinosinusitis
- Growing awareness about the benefits of drug therapy for rhinosinusitis
- Rising demand for minimally invasive sinus surgeries
- Technological advancements in drug delivery systems
- Growing number of clinical studies on new drugs and therapies for rhinosinusitis
Scope Of The Report
Report Attributes
Report Details
Report Title
Rhinosinusitis Drug Market Research Report
By Type
Antibiotics, Corticosteroids, Decongestants, Other
By Application
Acute Sinusitis, Chronic Sinusitis
By Companies
Sanofi, Bayer, Pfizer, AstraZeneca, Novartis, Johnson & Johnson, Merck, Amgen, Bionorica, Dr. Reddy's Laboratories, Huasun
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Rhinosinusitis Drug Market Report Segments:
The global Rhinosinusitis Drug market is segmented on the basis of:
Types
Antibiotics, Corticosteroids, Decongestants, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Acute Sinusitis, Chronic Sinusitis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Bayer
- Pfizer
- AstraZeneca
- Novartis
- Johnson & Johnson
- Merck
- Amgen
- Bionorica
- Dr. Reddy's Laboratories
- Huasun
Highlights of The Rhinosinusitis Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Corticosteroids
- Decongestants
- Other
- By Application:
- Acute Sinusitis
- Chronic Sinusitis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rhinosinusitis Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rhinosinusitis drug is a medication used to treat rhinosinusitis, an inflammation of the sinuses. It may be prescribed in combination with other medications.
Some of the major players in the rhinosinusitis drug market are Sanofi, Bayer, Pfizer, AstraZeneca, Novartis, Johnson & Johnson, Merck, Amgen, Bionorica, Dr. Reddy's Laboratories, Huasun.
The rhinosinusitis drug market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rhinosinusitis Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rhinosinusitis Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rhinosinusitis Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rhinosinusitis Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rhinosinusitis Drug Market Size & Forecast, 2020-2028
4.5.1 Rhinosinusitis Drug Market Size and Y-o-Y Growth
4.5.2 Rhinosinusitis Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Corticosteroids
5.2.3 Decongestants
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Acute Sinusitis
6.2.2 Chronic Sinusitis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rhinosinusitis Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rhinosinusitis Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Corticosteroids
9.6.3 Decongestants
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Acute Sinusitis
9.10.2 Chronic Sinusitis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Corticosteroids
10.6.3 Decongestants
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Acute Sinusitis
10.10.2 Chronic Sinusitis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Corticosteroids
11.6.3 Decongestants
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Acute Sinusitis
11.10.2 Chronic Sinusitis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Corticosteroids
12.6.3 Decongestants
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Acute Sinusitis
12.10.2 Chronic Sinusitis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Corticosteroids
13.6.3 Decongestants
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Acute Sinusitis
13.10.2 Chronic Sinusitis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rhinosinusitis Drug Market: Competitive Dashboard
14.2 Global Rhinosinusitis Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Bayer
14.3.3 Pfizer
14.3.4 AstraZeneca
14.3.5 Novartis
14.3.6 Johnson & Johnson
14.3.7 Merck
14.3.8 Amgen
14.3.9 Bionorica
14.3.10 Dr. Reddy's Laboratories
14.3.11 Huasun
